Detection of Nanobacteria-Like Particles in Human Atherosclerotic Plaques

Abstract

Recent and historical evidence is consistent with the view that atherosclerosis is an infectious disease or microbial toxicosis impacted by genetics and behavior. Because small bacterial-like particles, also known as nanobacteria have been detected in kidney stones, kidney and liver cyst fluids, and can form a calcium apatite coat we posited that this agent is present in calcified human atherosclerotic plaques. Carotid and aortic atherosclerotic plaques and blood samples collected at autopsy were examined for nanobacteria- like structures by light microscopy (hematoxylin-eosin and a calcium-specific von Kossa staining), immuno-gold labeling for transmission electron microscopy (TEM) for specific nanobacterial antigens, and propagation from homogenized, filtered specimens in culture medium. Nanobacterial antigens were identified in situ by immuno-TEM in 9 of 14 plaque specimens, but none of the normal carotid or aortic tissue (5 specimens). Nanobacteria-like particles were propagated from 26 of 42 sclerotic aorta and carotid samples and were confirmed by dot immunoblot, light microscopy and TEM. [3H]L-aspartic acid was incorporated into high molecular weight compounds of demineralized particles. PCR amplification of 16S rDNA sequences from the particles was unsuccessful by traditional protocols. Identification of nanobacteria-like particles at the lesion supports, but does not by itself prove the hypothesis that these agents contribute to the pathogenesis of atherosclerosis, especially vascular calcifications.

Abbreviations

DMEM:

Dulbecco’s Eagle’s medium

TEM:

transmission electron microscopy

NB:

nanobacteria

EM:

electronmicroscopy

FBS:

fetal bovine serum

LDL:

low density lipoprotein

EDTA:

ethylene-diamino-tetraacetate

BSA:

bovine serum albumin

PBS:

phosphate-buffered saline

FITC:

fluorescein-isothiocyanate

References

  1. 1.

    Sifil, A., Cavdar, C., Uretmen, P., Yavuzsen, T., Nazli, C., Camsari, T. (2000) Atherosclerotic heart disease in dialysis patients. Nephron 86, 387–388.

    Article  CAS  Google Scholar 

  2. 2.

    Kiechl, S., Egger, G., Mayr, M., Wiedermann, C. J., Bonora, E., Oberhollenzer, F., Muggeo, M., Xu, Q., Wick, G., Poewe, W., Willeit, J. (2001) Chronic infections and the risk of carotid atherosclerosis: Prospective results from a large population study. Circulation 103, 1064–1070.

    Article  CAS  Google Scholar 

  3. 3.

    Kessler, M. Atherosclerosis and hemodialysis. Nephrologie 21, 349–350.

  4. 4.

    Zoccali, C., Benedetto, F. A., Mallamaci, F., Tripepi, G., Fermo, I., Foca, A., Paroni, R., Malatoni, L. S. (2000) Inflammation is associated with carotid atherosclerosis in dialysis patients. Creed Investigators. Cardiovascular Risk Extended Evaluation in Dialysis Patients. J. Hypertens. 18, 1207–1213.

    Article  CAS  Google Scholar 

  5. 5.

    Lonnenmann, G. (2000) Chronic inflammation in hemodialysis: the role of contaminated dialysate. Blood Purif. 18, 214–223.

    Article  Google Scholar 

  6. 6.

    Zimmermann, J., Herrlinger, S., Pruy, A., Metzger, T., Wanner, C. (1999) Inflammation enhances cardiovascular risk and mortality in hemodialysis patients. Kidney Int. 55, 648–658.

    Article  CAS  Google Scholar 

  7. 7.

    Lopes-Virella, M. F., Virella, G. (1985) Immunological and microbiological factors in the pathogenesis of atherosclerosis. Clin. Immunol. Immunopathol. 37, 377–386.

    Article  CAS  Google Scholar 

  8. 8.

    Bachmaier, K., Le, J., Penninger, J. M. (2000) Catching heart disease: antigenic mimicry and bacterial infections. Nat. Med. 6, 841–842.

    Article  CAS  Google Scholar 

  9. 9.

    Burian, K., Kis, Z., Virok, D., Endresz, V., Prohaszka, Z., Duba, J., Berencsi, K., Boda, K., Horvath, L., Romics, L., Fust, G., Gonczol, E. (2001) Independent and joint effects of antibodies to human heat-shock protein 60 and Chlamydia pneumoniae infection in the development of coronary atherosclerosis. Circulation 103, 1503–1508.

    Article  CAS  Google Scholar 

  10. 10.

    Chiu, B. (1999) Multiple infections in carotid atherosclerotic plaques. Am. Heart. J. 138, S534–536.

    Article  CAS  Google Scholar 

  11. 11.

    Leionen, M., Saikku, P. (2000) Infections and atherosclerosis. Scand. Cardiovasc. J. 34, 12–20.

    Article  Google Scholar 

  12. 12.

    Ellis, R. W. (1997) Infection and coronary heart disease. J. Med. Microbiol. 46, 535–539.

    Article  CAS  Google Scholar 

  13. 13.

    Markus, H. S., Sitzer, M., Carrington, D., Mendall, M. A., Steinmetz, H. (1999) Chlamydia pneumoniae infection and early asymptomatic carotid atherosclerosis. Circulation 100, 832–837.

    Article  CAS  Google Scholar 

  14. 14.

    Stenvinkel, P., Heimburger, O., Jogestrand, T., Karnell, A., Samuelsson, A. (1999) Does persistent infection with Chlamydia pneumoniae increase the risk of atherosclerosis in chronic renal failure? Kidney Int. 55, 2531–2532.

    Article  CAS  Google Scholar 

  15. 15.

    Coles, K. A., Plant, A. J., Riley, T. V., Smith, D. W., McQuillan, B. M., Thompson, P. L. (1999) Lack of association between seropositivity to Chlamydia pneumoniae and carotid atherosclerosis. Am. J. Cardiol. 84, 825–828.

    Article  CAS  Google Scholar 

  16. 16.

    Gasbarrini, A., Cremonini, F., Armuzzi, A., Ojetti, V., Candelli, M., Di Campli, C., Sanz-Torre, E., Pola, R., Gasbarrini, G., Pola, P. (1999) The role of Helicobacter pylori in cardiovascular and cerebrovascular diseases. J. Physiol. Pharmacol. 50, 735–742.

    CAS  PubMed  Google Scholar 

  17. 17.

    Adam, E. (1987) High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 2, 291–293.

    Article  CAS  Google Scholar 

  18. 18.

    Horvath, R., Cerny, J., Benedik, J. Jr, Hokl, J., Jelinkova, I., Benedik, J. (2000) The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis. J. Clin. Virol. 16, 17–24.

    Article  CAS  Google Scholar 

  19. 19.

    Chiu, B., Viira, E., Tucker, W., Fong, I. W. (1997) Chlamydia pneumoniae, cytomegalovirus, and herpes simplex virus in atherosclerosis of the carotid artery. Circulation 96, 2144–2148.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. 20.

    Mininck, C. R., Fabricant, C. G., Fabricant, J., Litrenta, M. M. (1979) Atheroarteriosclerosis induced by infection with a herpesvirus. Am. J. Pathol. 96, 673–706.

    Google Scholar 

  21. 21.

    Wainwright, M. (1999) Nanobacteria and associated ‘elementary bodies’ in human disease and cancer. Microbiology 145, 2623–2624.

    Article  CAS  Google Scholar 

  22. 22.

    Wilson, P. W. F., Kauppila, L. I., O’Donnell, C. J., Kiel, D. P., Hannan, M., Polak, J. M., Cupples, A. (2001) Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation 103, 1529–1534.

    Article  CAS  Google Scholar 

  23. 23.

    Huang, H., Virmani, R., Younis, H., Burke, A. P., Kamm, R. D., Lee, R. T. (2001) The impact of calcification on the biomechanical stability of atherosclerotic plaques. Circulation 103, 1051–1056.

    Article  CAS  Google Scholar 

  24. 24.

    Shioi, A., Mori, K., Jono, S., Wakikawa, T., Hiura, Y., Koyama, H., Okuno, Y., Nishizawa, Y., Morii, H. (2000) Mechanism of atherosclerotic calcification. Z. Kardiol. 89 Suppl. 2, 75–79.

    Article  Google Scholar 

  25. 25.

    Shanahan, C. M., Proudfoot, D., Tyson, K. L., Cary, N. R., Edmonds, M., Weissberg, P. L. (2000) Expression of mineralisation-regulating proteins in association with human vascular calcification. Z. Kardiol. 89 Suppl. 2, 63–68.

    Article  Google Scholar 

  26. 26.

    Jeziorska, M., McCollum, C., Woolley, D. E. (1998) Calcification in atherosclerotic plaque of human carotid arteries: associations with mast cells and macrophages. J. Pathol. 185, 10–17.

    Article  CAS  Google Scholar 

  27. 27.

    Hsu, H. H., Tawfik, O., Sun, F. (2000) Effects of lectins on calcification by vesicles isolated from aortas of cholesterol-fed rabbits. Biochim. Biophys. Acta 1464, 262–272.

    Article  CAS  Google Scholar 

  28. 28.

    Kajander, E. O., Ciftcioglu, N. (1998) Nanobacteria: an alternative mechanism for pathogenic intraand extracellular calcification and stone formation. Proc. Natl. Acad. Sci. USA 95, 8274–8279.

    Article  CAS  Google Scholar 

  29. 29.

    Kajander, E. O., Kuronen, I., Åkerman, K., Pelttari, A., Ciftcioglu, N. (1997) Nanobacteria from blood, the smallest culturable autonomously replicating agent on Earth. Proc. SPIE Int. Soc. Opt. Eng. 3111, 420–428.

    CAS  Google Scholar 

  30. 30.

    Ciftcioglu, N., Bjorklund, M., Kuorikoski, K., Bergstrom, K., Kajander, E. O. (1999) Nanobacteria: an infectious cause for kidney stone formation. Kidney Int. 56, 1893–1898.

    Article  CAS  Google Scholar 

  31. 31.

    Hjelle, J. T., Miller-Hjelle, M. A., Poxton, I. R., Kajander, E. O., Ciftcioglu, N., Jones, M. L., Caughey, R. C., Brown, R., Millikin, P. D., Darras, F. S. (2000) Endotoxin and nanobacteria in polycystic kidney. Kidney Int. 57, 2360–2374.

    Article  CAS  Google Scholar 

  32. 32.

    Kajander, E. O., Ciftcioglu, N., Miller-Hjelle, M. A., Hjelle, J. T. (2001) Nanobacteria: controversial pathogens in nephrolithiasis and polycystic kidney disease. Curr. Opin. Nephrol. Hypertens. 10, 445–452.

    Article  CAS  Google Scholar 

  33. 33.

    Franklin, R. M., Martin, M. T. (1980) Staining and histochemistry of undecalcified bone embedded in a water-miscible plastic. Stain Technol. 55, 313–321.

    Article  CAS  Google Scholar 

  34. 34.

    Cisar, J. O., Xu, D. Q., Thompson, J., Swaim, W., Hu, L., Kopecko, D. J. (2000) An alternative interpretation of nanobacteria-induced biomineralization. Proc. Natl. Acad. Sci. USA 97, 11511–11515.

    Article  CAS  Google Scholar 

  35. 35.

    Ciftcioglu, N., Kajander, E. O. (1998) Interaction of nanobacteria with cultured mammalian cells. Pathophysiology 4, 259–270.

    Article  Google Scholar 

  36. 36.

    Ciftcioglu, N., Miller-Hjelle, M. A., Hjelle, J. T., Kajander, E. O. (2002) Inhibition of nanobacteria by antimicrobial drugs as measured by a modified microdilution method. Antimicrob. Agents Chemother. 46, 2077–2086.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. 37.

    Barr, S. C., Linke, R. A., Janssen, D., Guard, C. L., Smith, M. C., Daugherty, C. S., Scarlett, J. M. (2003) Detection of biofilm formation and nanobacteria under long-term cell culture conditions in serum samples of cattle, goats, cats, and dogs. Am. J. Vet. Res. 64, 176–182.

    Article  Google Scholar 

  38. 38.

    Kajander, E. O., Ciftcioglu, N., Aho, K., Garcia-Cuerpo, E. (2003) Characteristics of nanobacteria and their possible role in stone formation. Urol. Res. 31, 47–54.

    PubMed  Google Scholar 

  39. 39.

    Conte, V. A., Grases, F. F., Costa-Bauza, A., Piza, R. P. (2001) Microinfections and kidney lithiasis. Arch. Esp. Urol. 54, 855–860.

    Google Scholar 

  40. 40.

    Li, Y., Wen, Y., Yang, Z., Wei, H., Liu, W., Tan, A., Wu, X., Wang, Q., Huang, S., Kajander, E. O., Ciftcioglu, N. (2002) Culture and identification of nanobacteria in bile. Zhonghua Yi Xue Za Zhi. 82, 1557–1560.

    CAS  PubMed  Google Scholar 

  41. 41.

    Morgan, M. B. (2002) Nanobacteria and calcinosis cutis. J. Cutan Pathol. 29, 173–175.

    Article  Google Scholar 

  42. 42.

    Drancourt, M., Jacomo, V., Lepidi, H., Lechevallier, E., Grisoni, V., Coulange, C., Ragni, E., Alasia, C., Dussol, B., Berland, Y., Raoult, D. (2003) Attempted isolation of Nanobacterium sp. microorganisms from upper urinary tract stones. J. Clin. Microbiol. 41, 368–372.

    Article  PubMed  PubMed Central  Google Scholar 

  43. 43.

    Price, P. A., Thomas, G. R., Pardini, A. W., Figueira, W. F., Caputo, J. M., Williamson, M. K. (2002) Discovery of a high molecular weight complex of calcium, phosphate, fetuin, and matrix gamma-carboxyglutamic acid protein in the serum of etidronate-treated rats. J. Biol. Chem. 277, 3926–3934.

    Article  CAS  Google Scholar 

  44. 44.

    Price, P. A., Lim, J. E. (2003) The inhibition of calcium phosphate precipitation by fetuin is accompanied by the formation of a fetuin-mineral complex. J. Biol. Chem. 278, 22144–22152.

    Article  CAS  Google Scholar 

  45. 45.

    Khullar, M., Sharma, S. K., Singh, S. K., Bajwa, P., Sheikh, F. A., Relan, V., Sharma, M. (2004) Morphological and immunological characteristics of nanobacteria from human renal stones of a north Indian population. Urol. Res. 32, 190–195.

    Article  CAS  Google Scholar 

  46. 46.

    Ciftcioglu, N., McKay, D. S., Kajander, E. O. (2003) Association between nanobacteria and periodontal disease. Circulation 108, 58–59.

    Google Scholar 

  47. 47.

    Sedivy, R., Battistutti, W. B. (2003) Nanobacteria promote crystallization of psammoma bodies in ovarian cancer. APMIS 111, 951–4.

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to L. G. Puskás.

Rights and permissions

This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

Reprints and Permissions

About this article

Cite this article

Puskás, L.G., Tiszlavicz, L., Rázga, Z. et al. Detection of Nanobacteria-Like Particles in Human Atherosclerotic Plaques. BIOLOGIA FUTURA 56, 233–245 (2005). https://doi.org/10.1556/ABiol.56.2005.3-4.7

Download citation

Keywords

  • Nanobacteria-like particles
  • atherosclerosis
  • carotid artery
  • aorta
  • vascular plaque